Department of Health and Human Services June 4, 2015 – Federal Register Recent Federal Regulation Documents
Results 1 - 6 of 6
Withdrawal of Approval of New Animal Drug Application; Chlortetracycline
The Food and Drug Administration (FDA) is withdrawing approval of a new animal drug application (NADA). This action is being taken at the sponsors' request because this product is no longer manufactured or marketed.
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
The meeting announced in this notice concerns Natural Experiments of the Impact of Population-targeted Health Policies to Prevent Diabetes and its Complications, DP15-001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA), RFA-EH-15-001, Environmental Health Specialists Network (EH-Net) Practice based research to improve food safety.
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA), RFA-CE-15-002, The CDC National Center for Excellence in Youth Violence Prevention: Building the Evidence for Community- and Policy-Level Prevention.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
